ArticleOncology letters2018

Dihydroartemisinin triggers c-Myc proteolysis and inhibits protein kinase B/glycogen synthase kinase 3β pathway in T-cell lymphoma cells.

Wenwen Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.